Valuation: BOIRON

Market Cap 477M 546M 440M 407M 772M 52.06B 785M 5.26B 2.07B 25.65B 2.05B 2B 88.17B P/E 2024
41x
P/E 2025 16.1x
Enterprise Value 430M 491M 396M 366M 694M 46.84B 706M 4.73B 1.86B 23.08B 1.84B 1.8B 79.33B EV / Sales 2024
0.85x
EV / Sales 2025 0.95x
Free-Float
19.96%
Yield 2024
4.48%
Yield 2025 4.46%
1 week-0.73%
Current month-2.52%
1 month-4.24%
3 months+2.26%
6 months-9.06%
Current year-9.06%
1 week 27
Extreme 27
27.3
1 month 27
Extreme 27
28.2
3 years 20.5
Extreme 20.5
55.9
5 years 20.5
Extreme 20.5
55.9
10 years 20.5
Extreme 20.5
91.9
Manager TitleAgeSince
Chief Executive Officer 57 2024-12-31
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer - 2021-12-31
Director TitleAgeSince
Chairman 65 2011-06-30
Director/Board Member 54 2010-03-09
Director/Board Member 51 2013-05-22
Change 5-day change 1-year change 3-year change Capi.($)
+0.37%-0.74%+21.80%-45.91% 546M
+0.95%-0.08%-12.82%-8.16% 12.85B
+2.42%+1.37%-33.43%-54.80% 4.79B
-0.02%-0.64%-6.89%-5.76% 4.4B
-7.84%-7.31%+12.48%-9.74% 3.68B
+2.11%-0.70%+4.02%-37.69% 3.82B
-0.58%+6.63%-8.69%-13.03% 3.26B
+0.28%+0.57%-11.39%+2.92% 3.1B
-0.77%+1.24%-7.85%-23.20% 2.41B
-0.32%+4.78%-5.40%+44.70% 1.8B
Average -0.42%-1.14%-4.82%-15.07% 4.46B
Weighted average by Cap. -0.01%-1.26%-9.20%-14.91%

Financials

2024 2025
Net sales 488M 557M 450M 415M 788M 53.16B 801M 5.37B 2.11B 26.19B 2.09B 2.05B 90.03B 501M 573M 462M 427M 810M 54.64B 824M 5.52B 2.17B 26.92B 2.15B 2.1B 92.53B
Net income 11.34M 12.96M 10.46M 9.66M 18.32M 1.24B 18.63M 125M 49.06M 609M 48.66M 47.6M 2.09B 32.64M 37.32M 30.11M 27.81M 52.77M 3.56B 53.65M 360M 141M 1.75B 140M 137M 6.03B
Net Debt -49.74M -56.86M -45.88M -42.37M -80.4M -5.42B -81.75M -548M -215M -2.67B -214M -209M -9.18B -47.86M -54.71M -44.14M -40.77M -77.36M -5.22B -78.66M -527M -207M -2.57B -205M -201M -8.84B
Logo BOIRON
Laboratoires BOIRON was founded in France almost a century ago, under the impetus of homeopathic doctors who wanted to benefit from the most reliable medicines possible. Homeopathic medicines have many advantages in that they can be prescribed and advised in first line whenever relevant, in both urban and hospital settings. All actions aim to contribute to major public health issues. Homeopathic medicines are obtained from substances called homeopathic strains, according to a manufacturing process described in the pharmacopoeia. These strains can be of plant, animal, mineral or chemical origin. There are two main families of homeopathic medicines: common name homeopathic medicines and brand name homeopathic medicines (specialties). BOIRON group centralizes its production and logistics in France. It also has 26 wholly-owned or leased distribution facilities in France and various offices in the countries where it has subsidiaries. Net sales are distributed geographically as follows: France (43.5%), Europe (24%), North America (27.5%) and other (5%).
Employees
-
Date Price Change
26-07-10 €27.10 +0.37%
26-07-09 €27.00 0.00%
26-07-08 €27.00 0.00%
26-07-07 €27.00 -1.10%
26-07-06 €27.30 0.00%

Annual profits - Rate of surprise